Work Here?
About Revance
Industries
Fintech
Biotechnology
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
Nashville, Tennessee
Founded
1999
Overview
Revance Therapeutics focuses on biotechnology solutions in the aesthetics market, offering products that enhance physical appearance and improve patient outcomes. Their main products include neuromodulators, like botulinum toxin type A, which reduce wrinkles and treat muscle movement disorders, and dermal fillers that restore volume and smooth facial lines. Revance is also exploring therapeutic uses for these products to address muscle movement and pain disorders. A unique aspect of Revance is its expansion into the fintech sector with the acquisition of HintMD, a platform that simplifies payment processes for aesthetic practices. This integration allows Revance to provide a comprehensive service suite for aesthetic practitioners. The company aims to lead the premium aesthetics market by focusing on differentiated products and improved patient experiences.
Simplify's Take
What believers are saying
- Growing interest in minimally invasive procedures benefits Revance's aesthetic product offerings.
- Fintech integration in aesthetics enhances customer satisfaction and retention for Revance.
- Global botulinum toxin market growth supports Revance's neuromodulator product expansion.
What critics are saying
- Evolus's Jeuveau targets younger demographics, potentially capturing Revance's market share.
- Class action lawsuit poses financial liabilities and reputational damage to Revance.
- Minimum purchase obligations under Distribution Agreement present financial risks for Revance.
What makes Revance unique
- Revance integrates fintech solutions like HintMD to streamline aesthetic practice payments.
- The company focuses on innovative neuromodulators and dermal fillers for aesthetic treatments.
- Revance targets personalized medicine trends with differentiated dermatology and aesthetic products.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$2485M
Above
Industry Average
Funded Over
9 Rounds
Benefits
Health Insurance
Unlimited Paid Time Off
401(k) Company Match
Professional Development Budget
Growth & Insights and Company News
6 month growth
↓ -2%1 year growth
↓ -3%2 year growth
↑ 0%Evolus has strategically targeted a younger audience with its wrinkle treatment Jeuveau, setting itself apart from competitors like Revance and AbbVie, which usually focus on clients in their 40s.
In addition, under the Distribution Agreement, Revance is required to meet certain minimum purchase obligations and certain minimum expenditure requirements and either party may terminate the Distribution Agreement in the event of "a material breach by the other party."
Crown offer of $3.65 per share is the only offer available to Revance stockholders. Crown offer unanimously approved by the Revance Board of Directors. Teoxane withdraws its previous proposal, says it will tender its 6.2% stake in Revance into Crown tender
Revance Therapeutics is set to go private with Crown Laboratories by Feb. 6. Crown has increased its offer to $3.65 per share, a 17% rise from the previous $3.10 offer. The deal, endorsed by Revance's board, is the only fully-financed offer available. The initial $6.66 offer was paused due to a breach with Teoxane, but a settlement has been reached. Revance's shares were trading at $3.63, with a 52-week range of $2.30-$7.56. The offer is valid until Feb. 4.
From Washington, DC but with Oak Ridge ties: Teresa Robbins has been named as the Acting Administrator of the National Nuclear Security Administration (NNSA). Prior to this, she served as... The post News Notes | Acting Administrator of National Nuclear Security Administration has Oak Ridge ties appeared first on Teknovation.biz.
Revance is Hiring for 14 Jobs on Simplify!
Find jobs on Simplify and start your career today
People Also Viewed
Discover companies similar to Revance
About Revance
Industries
Fintech
Biotechnology
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
Nashville, Tennessee
Founded
1999
Revance is Hiring for 14 Jobs on Simplify!
Find jobs on Simplify and start your career today
People Also Viewed
Discover companies similar to Revance